Extrapulmonary Neuroendocrine Carcinoma — An Interview with Dr Jonathan Strosberg on Current and Future Management (Companion Faculty Lecture)
Research To Practice | Oncology Videos
00:00
Ongoing DLL3‑Directed Trials and Alternative Approaches
Strosberg outlines multiple DLL3 trials, including antibody‑drug conjugates, radiopharmaceuticals, and CAR‑T strategies.
Play episode from 22:34
Transcript
